LV13361B - Method of obtaining cell lines in a protein-free medium and cell lines thus obtained - Google Patents

Method of obtaining cell lines in a protein-free medium and cell lines thus obtained Download PDF

Info

Publication number
LV13361B
LV13361B LVP-05-61A LV050061A LV13361B LV 13361 B LV13361 B LV 13361B LV 050061 A LV050061 A LV 050061A LV 13361 B LV13361 B LV 13361B
Authority
LV
Latvia
Prior art keywords
protein
protein concentration
concentration
cell line
medium
Prior art date
Application number
LVP-05-61A
Other languages
English (en)
Latvian (lv)
Inventor
Rodriguez Rolando Perez
Vitlloch Adolfo Castillo
Sarazola Svieta Vitores
Ayo Tammy Boggiano
Del Calvo Luis Rojas
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of LV13361B publication Critical patent/LV13361B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
LVP-05-61A 2002-10-23 2005-05-23 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained LV13361B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020239A CU23097A1 (es) 2002-10-23 2002-10-23 Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método

Publications (1)

Publication Number Publication Date
LV13361B true LV13361B (en) 2006-02-20

Family

ID=40134843

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-05-61A LV13361B (en) 2002-10-23 2005-05-23 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained

Country Status (27)

Country Link
US (2) US20060036082A1 (fr)
EP (2) EP2363418B1 (fr)
JP (1) JP4674087B2 (fr)
KR (1) KR101186048B1 (fr)
CN (1) CN1714147B (fr)
AR (1) AR041645A1 (fr)
AT (1) ATE502103T1 (fr)
AU (1) AU2003273727B2 (fr)
BR (1) BR0315565B1 (fr)
CA (1) CA2503315C (fr)
CU (1) CU23097A1 (fr)
DE (1) DE60336415D1 (fr)
DK (1) DK1564285T3 (fr)
EA (1) EA007465B1 (fr)
EC (1) ECSP055740A (fr)
ES (2) ES2624279T3 (fr)
GE (1) GEP20084444B (fr)
HR (1) HRP20050760A2 (fr)
LT (1) LT5354B (fr)
LV (1) LV13361B (fr)
MY (1) MY144088A (fr)
NZ (1) NZ540171A (fr)
PE (1) PE20040552A1 (fr)
PT (1) PT1564285E (fr)
TN (1) TNSN05116A1 (fr)
UY (1) UY28037A1 (fr)
WO (1) WO2004038010A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104673754B (zh) * 2015-02-14 2018-03-02 百泰生物药业有限公司 重组骨髓瘤细胞克隆的筛选方法及由此获得的抗体分子
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694263A (en) * 1970-10-23 1972-09-26 Joseph J Korn Sr Swimming pool cleaning methods and apparatus therefor
CU22545A1 (es) * 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US3886616A (en) * 1972-12-06 1975-06-03 Fay A Hayes Hand propelled swimming pool cleaner
US4275474A (en) * 1979-04-30 1981-06-30 Woodard Randle C Vacuum head for swimming pool cleaning system
US4240174A (en) * 1979-07-30 1980-12-23 Scott Jeffrey L Self-contained mobile pool cleaning apparatus
US4430214A (en) * 1982-09-15 1984-02-07 Baker Marvin E Strainer mill for swimming pool pump intake
AU2986484A (en) * 1983-06-27 1985-01-03 Monash University Leptospira strains grown in protein free medium
US4558479A (en) * 1984-01-26 1985-12-17 Alopex Industries, Inc. Pool cleaner
US4683599A (en) * 1984-03-30 1987-08-04 Fahet Nv Automatic pool cleaner fitting
US4581075A (en) * 1985-03-15 1986-04-08 Maxi-Sweep, Inc. Self-propelled water borne pool cleaner
AU6291090A (en) 1989-09-29 1991-04-28 Atomic Energy Of Canada Limited Infrared-based gas detector
JP2696001B2 (ja) 1991-04-15 1998-01-14 財団法人化学及血清療法研究所 組換え蛋白質産生用培地
EP0531562A1 (fr) 1991-09-11 1993-03-17 Doerr, Hans-Wilhelm, Prof. Dr. med. Culture de cellules de mammifères
EP0784684B8 (fr) * 1994-09-16 2008-03-26 Cancer Research Institute of Contra Costa PEPTIDES RECOMBINANTS DERIVES DE L'ANTICORPS Mc3 DIRIGE CONTRE L'ANTIGENE BA46, LEURS PROCEDES D'UTILISATION ET PROCEDES D'HUMANISATION D'ANTICORPS PEPTIDIQUES
ATE542891T1 (de) 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur
CA2211630A1 (fr) 1995-02-23 1996-08-29 Quest International B.V. Peptides destines a des milieux de culture tissulaire et cellulaire
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
CU22584A1 (es) * 1995-11-17 1999-11-03 Centro Inmunologia Molecular Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
AT407255B (de) * 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons

Also Published As

Publication number Publication date
DE60336415D1 (de) 2011-04-28
EA007465B1 (ru) 2006-10-27
ECSP055740A (es) 2005-09-20
HRP20050760A2 (en) 2006-08-31
EP2363418A3 (fr) 2011-11-16
ES2624279T3 (es) 2017-07-13
UY28037A1 (es) 2004-04-30
GEP20084444B (en) 2008-08-10
ES2360049T3 (es) 2011-05-31
PT1564285E (pt) 2011-04-20
WO2004038010A1 (fr) 2004-05-06
NZ540171A (en) 2008-04-30
BR0315565A (pt) 2005-08-23
CN1714147A (zh) 2005-12-28
DK1564285T3 (da) 2011-05-16
CA2503315A1 (fr) 2004-05-06
HK1084414A1 (en) 2006-07-28
PE20040552A1 (es) 2004-10-26
LT2005053A (en) 2006-04-25
EP1564285B1 (fr) 2011-03-16
EP2363418A2 (fr) 2011-09-07
CN1714147B (zh) 2011-01-12
EA200500695A1 (ru) 2005-10-27
MY144088A (en) 2011-08-15
KR101186048B1 (ko) 2012-09-25
EP1564285A1 (fr) 2005-08-17
CA2503315C (fr) 2014-02-18
AU2003273727B2 (en) 2008-04-03
US20060036082A1 (en) 2006-02-16
AR041645A1 (es) 2005-05-26
EP2363418B1 (fr) 2017-02-08
JP4674087B2 (ja) 2011-04-20
CU23097A1 (es) 2005-11-18
AU2003273727A1 (en) 2004-05-13
JP2006503879A (ja) 2006-02-02
TNSN05116A1 (en) 2007-05-14
US20100197011A1 (en) 2010-08-05
KR20050088403A (ko) 2005-09-06
LT5354B (lt) 2006-07-25
BR0315565B1 (pt) 2022-01-25
ATE502103T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
JP4231862B2 (ja) リンパ球抗原ｃｄ２および腫瘍抗原を認識する二特異性トリガー分子
WO2005070120A2 (fr) Milieu de culture de cellules
JP2017516484A (ja) タンパク質生産のための細胞培養工程
US20100197011A1 (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
JP7842737B2 (ja) 細胞培養プロセス
HK1162036A (en) Method of obtaining recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media
KR20250073557A (ko) 단백질 산물을 제조하는 방법
EP0251106A2 (fr) Méthode de fusion
BRPI0315565B1 (pt) Método para se obter uma linhagem celular de mieloma nso que contém uma sequência que codifica um polipeptídeo recombinante ou uma proteína recombinante adaptada para crescer em meio livre de soro e proteína, e, uso do método
HK1084414B (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
CN109715786A (zh) 调节重组蛋白生产状况的方法
JPS60204727A (ja) 抗ヒトｖ型コラ−ゲン抗体
JP3029635B2 (ja) 抗体産生変異株の取得方法
JPS61219381A (ja) ヒト−ヒトハイブリド−マ